CIK 0001433607 · Non-accelerated filer<br>Smaller reporting company
InspireMD, Inc.
Sign in to watch- Ticker
- NSPR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262123838
- Phone
- (888) 776-6804
- Business address
- 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
- Former names
- Saguaro Resources, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | BERMAN MICHAEL Director | Other disposition · Series J Warrant (right to buy) | −30,625 | 30,624 | ||
| 2026-09-18 | BERMAN MICHAEL Director | Other acquisition · Series J Warrant (right to buy) | +30,625 | 30,625 | ||
| 2026-09-18 | BERMAN MICHAEL Director | Other disposition · Series K Warrant (right to buy) | −61,248 | 0 | ||
| 2026-09-18 | BERMAN MICHAEL Director | Other acquisition · Series K Warrant (right to buy) | +61,248 | 61,248 | ||
| 2026-09-18 | ROUBIN GARY S Director | Other disposition · Series J Warrant (right to buy) | −15,313 | 15,312 | ||
| 2026-09-18 | ROUBIN GARY S Director | Other acquisition · Series J Warrant (right to buy) | +15,313 | 15,313 | ||
| 2026-09-18 | ROUBIN GARY S Director | Other disposition · Series K Warrant (right to buy) | −30,624 | 0 | ||
| 2026-09-18 | ROUBIN GARY S Director | Other acquisition · Series K Warrant (right to buy) | +30,624 | 30,624 | ||
| 2026-09-18 | Stuka Paul Director | Other disposition · Series J Warrant (right to buy) | −43,750 | 43,750 | ||
| 2026-09-18 | Stuka Paul Director | Other acquisition · Series J Warrant (right to buy) | +43,750 | 43,750 | ||
| 2026-09-18 | Stuka Paul Director | Other disposition · Series K Warrant (right to buy) | −87,500 | 0 | ||
| 2026-09-18 | Stuka Paul Director | Other acquisition · Series K Warrant (right to buy) | +87,500 | 43,750 | ||
| 2026-05-27 | Stuka Paul Director | Purchase | +20,000 | $0.88 | $18K | 667,871 |
| 2026-05-19 | Gleason Shane Thomas Chief Commercial Officer | Sale | −22,778 | $1.01 | $23K | 1,053,882 |
| 2026-05-14 | Stuka Paul Director | Purchase | +5,000 | $1.15 | $6K | 647,871 |
| 2026-05-13 | Stuka Paul Director | Purchase | +10,000 | $1.16 | $12K | 642,871 |
| 2026-05-12 | Slosman Marvin CEO and President | Purchase | +21,000 | $1.20 | $25K | 3,556,658 |
| 2026-05-11 | Stuka Paul Director | Purchase | +10,000 | $1.19 | $12K | 632,871 |
| 2026-05-11 | Stuka Paul Director | Purchase 10b5-1 | +10,000 | $1.19 | $12K | 632,871 |
| 2026-05-08 | Stuka Paul Director | Purchase | +65,626 | $1.16 | $76K | 622,871 |
Page 1 of 10 · 195 trades